PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Oxygen chamber study targets dozens of diseases from long COVID to frostbite
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) in 100 people with various conditions, including long COVID, Crohn's disease, frostbite, and more. HBOT involves breathing pure oxygen in a pressurized chamber to help the body heal. The goal is to see if HBOT improves quality…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated May 17, 2026 10:10 UTC
-
New shot aims to heal stubborn skin ulcers in rare disease
Disease control Not yet recruitingThis early study tests an injection called SHR-1139 in 10 adults with ulcerative pyoderma gangrenosum, a rare condition causing painful skin ulcers. The main goal is to see if the treatment can fully close the target ulcer by 12 weeks. Researchers will also check for side effects…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated May 17, 2026 10:10 UTC
-
New shot aims to heal painful skin ulcers in rare disease
Disease control Not yet recruitingThis study tests an experimental drug called SHR-1139 in 20 adults with pyoderma gangrenosum, a rare condition causing painful skin ulcers. The main goal is to see if the drug can completely close the largest ulcer and keep it closed. Researchers will also check for side effects …
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 17, 2026 10:09 UTC